Growth regulation of primary human keratinocytes by prostaglandin E receptor EP2 and EP3 subtypes

Biochimica et Biophysica Acta - Molecular Cell Research

Volumn 1401, Issue 2, 1998, Pages 221-234

  Konger, Raymond L ^a   Malaviya, Rama ^b   Pentland, Alice P ^c  

^a Division of Laboratory Medicine   (United States)

^b PARKER HUGHES INSTITUTE   (United States)

^c UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

Author keywords

(Human); Cyclic AMP; Keratinocyte; Proliferation; Prostaglandin E receptor; Receptor agonist

Indexed keywords

CYCLIC AMP; MISOPROSTOL; PROSTAGLANDIN DERIVATIVE; PROSTAGLANDIN E RECEPTOR; RECEPTOR SUBTYPE;

ARTICLE; CELL PROLIFERATION; DRUG EFFECT; DRUG RECEPTOR BINDING; GROWTH INHIBITION; GROWTH REGULATION; HUMAN; HUMAN CELL; KERATINOCYTE; NORTHERN BLOTTING; PRIORITY JOURNAL; PROTEIN DETERMINATION; RECEPTOR DENSITY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION;

ABORTIFACIENT AGENTS, NONSTEROIDAL; ADENYLATE CYCLASE; BROMODEOXYURIDINE; BUCLADESINE; CELL DIVISION; CYCLOOXYGENASE INHIBITORS; DINOPROSTONE; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME ACTIVATION; GENE EXPRESSION; HUMANS; INDOMETHACIN; KERATINOCYTES; MISOPROSTOL; OXYTOCICS; RECEPTORS, PROSTAGLANDIN E; RNA; TRANSCRIPTION, GENETIC;

EID: 0032481417     PISSN: 01674889     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0167-4889(97)00114-6     Document Type: Article

References (61)

1. Pentland A.P., George J., Moran C., Needleman P. Biochim. Biophys. Acta. 919:1987;71-78.
2. Lord J.T., Ziboh V.A., Cagle W.D., Kursunoglu S., Redmond G. Adv. Prostaglan. Thrombox. Res. 7:1980;865-869.
3. Vanderveen E.E., Grekin R.C., Swanson N.A., Kragballe K. Arch. Dermatol. 122:1986;407-412.
4. Giardiello F.M., Offerhaus G.J., DuBois R.N. Eur. J. Cancer. 31A:1995;1071-1076.
5. Reeve V.E., Metheson M.J., Bosnic M., Boehm-Wilcox C. Cancer Lett. 95:1995;213-219.
6. Shibata M.A., Hasegawa R., Shirai T., Takesada Y., Fukushima S. Int. J. Cancer. 55:1993;1011-1017.
7. Marks F., Furstenberger G., Heinzelmann T., Muller-Decker K. Toxicol. Lett. 82:1995;907-917.
8. Pollard M., Luckert P.H. Science. 214:1981;558-559.
9. Negishi M., Sugimoto Y., Ichikawa A. J. Lipid Mediators Cell Signal. 12:1995;379-391.
10. Ushikubi F., Hirata M., Narumiya S. J. Lipid Mediators Cell Signal. 12:1995;343-359.
11. Schmid A., Thierauch K.H., Schleuning W.D., Dinter H. Eur. J. Biochem. 228:1995;23-30.
12. Kotani M., Tanaka I., Ogawa Y., Usui T., Mori K., Ichikawa A., Narumiya S., Yoshimi T., Nakao K. Mol. Pharmacol. 48:1995;869-879.
13. Regan J.W., Bailey T.J., Donello J.E., Pierce K.L., Pepperl D.J., Zhang D., Kedzie K.M., Fairbairn C.E., Bogardus A.M., Woodward D.F., Gil D.W. Br. J. Pharmacol. 112:1994;377-385.
14. Sakai H., Kumano E., Ikari A., Takeguchi N. J. Biol. Chem. 270:1995;18781-18785.
15. An S., Yang J., So S.W., Zeng L., Goetzl E.J. Biochemistry. 33:1994;14496-14502.
16. Asboth G., Phaneuf S., Europe-Finner G.N., Toth M., Bernal A.L. Endocrinology. 137:1996;2572-2579.
17. Goldyne M.E. J. Invest. Dermatol. 64:1975;377-385.
18. Zhang J., Maruyama K., Iwatsuki K., Ono I., Kaneko F. Exp. Dermatol. 3:1994;164-170.
19. Bentley-Phillips C.B., Paulli-Jorgensen H., Marks R. Arch. Dermatol. Res. 257:1977;233-237.
20. Lowe N.J., Stoughton R.B. J. Invest. Dermatol. 68:1977;134-137.
21. Lupulescu A. Prostaglandins. 10:1975;573-579.
22. Pentland A.P., Needleman P. J. Clin. Invest. 77:1986;246-251.
23. Francis A.J., Marks R. Br. J. Dermatol. 97:1977;395-399.
24. Marks R., Francis A.J. Br. J. Dermatol. 97:1977;395-399.
25. Hulsey T.K., O'Neill J.A., Neblett W.R., Meng H.C. J. Pediatr. Surg. 15:1980;505-508.
26. Rolland P.H., Martin P.M., Jacquemier J., Rolland A.M., Toga M. J. Natl. Cancer Inst. 64:1980;1061-1070.
27. Botha J.H., Robinson K.M., Ramchurren N., Reddi K., Norman R.J. J. Natl. Cancer Inst. 76:1986;1053-1056.
28. Klapan I., Katic V., Culo F., Cuk V. J. Cancer Res. Clin. Oncol. 118:1992;308-313.
29. Culo F., Klapan I., Katic V., Kolak T., Bakula B. Med. Oncol. Tumor Pharmacother. 9:1992;35-39.
30. Lupulescu A. Oncology. 37:1980;418-423.
31. Snyderman C.H., Abbas M.M., Wagner R., D'Amico F. Arch. Otolaryngol. Head Neck Surg. 121:1995;1017-1020.
32. Noguchi M., Earashi M., Miyazaki I., Tanaka M., Sasaki T. Prostaglandins Leukotrienes Essent. Fatty Acids. 52:1995;381-386.
33. ElAttar T.M., Lin H.S. J. Oral Pathol. Med. 22:1993;425-427.
34. McKenzie K.E., Bandyopadhyay G.K., Imagawa W., Sun K., Nandi S. Prostaglandins Leukotrienes Essent. Fatty Acids. 51:1994;37-43.
35. Planchon P., Veber N., Magnien V., Israel L., Starzec A.B. Mol. Cell. Endocrinol. 111:1995;219-223.
36. Fulton A.M., Laterra J.J., Hanchin C.M. J. Cell. Physiol. 139:1989;93-99.
37. Green H. Cell. 15:1978;801-811.
38. Takahashi K., Nakanishi S., Imamura S. J. Invest. Dermatol. 101:1993;646-651.
39. Ethier S.P., van de Velde R.M., Cundiff K.C. Exp. Cell Res. 182:1989;653-658.
40. Adachi K., Yoshikawa K., Halprin K.M., Levine V. Br. J. Dermatol. 92:1975;381-388.
41. Lord J.T., Ziboh V.A., Warren S.K. Endocrinology. 102:1978;1300-1309.
42. Lord J.T., Ziboh V.A. J. Invest. Dermatol. 73:1979;373-377.
43. Marks R. Cancer. 75:1995;607-612.
44. Magaud J.P., Sargent I., Mason D.Y. J. Immunol. Methods. 106:1988;95-100.
45. Chomczynski P., Sacchi N. Anal. Biochemistry. 162:1987;156-159.
46. Bastien L., Sawyer N., Grygorczyk R., Metters K.M., Adam M. J. Biol. Chem. 269:1994;11873-11877.
47. Regan J.W., Bailey T.J., Pepperl D.J., Pierce K.L., Bogardus A.M., Donello J.E., Fairbairn C.E., Kedzie K.M., Woodward D.F., Gil D.W. Mol. Pharmacol. 46:1994;213-220.
48. Negishi M., Sugimoto Y., Atsushi I., Narumiya S., Ichikawa A. J. Biol. Chem. 268:1993;9517-9521.
49. Zeng L., An S., Goetzl E.J. Immunology. 86:1995;620-628.
50. Bata-Csorgo Z., Hammerberg C., Voorhees J.J., Cooper K.D. J. Clin. Invest. 95:1995;317-327.
51. Mansbridge J.N., Knapp A.M. J. Invest. Dermatol. 89:1987;253-263.
52. Konger R.L., Chan T.C.K. J. Cell. Physiol. 156:1993;515-521.
53. Iwashita S., Mitsui K., Shoji-Kasai Y., Senshu-Miyaike M. J. Biol. Chem. 265:1990;10702-10708.
54. McCall C.A., Cohen J.J. J. Invest. Dermatol. 97:1991;111-114.
55. Goetzl E.J., An S., Zeng L. J. Immunology. 154:1995;1041-1047.
56. Tsujii M., DuBois R.N. Cell. 83:1995;493-501.
57. Reiners J.J., Slaga T.J. Cell. 32:1983;247-255.
58. Le Panse R., Coulomb B., Mitev V., Bouchard B., Lebreton C., Dubertret L. Mol. Pharmacol. 46:1994;445-451.
59. Evans C.B., Pillai S., Goldyne M.E. Prostaglandins Leukotrienes Essent. Fatty Acids. 49:1993;777-781.
60. Coleman R.A., Grix S.P., Head S.A., Louttit J.B., Mallett A., Sheldrick R.L. Prostaglandins. 47:1994;151-168.
61. Lawrence R.A., Jones R.L. Br. J. Pharmacol. 105:1992;817-824.